Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas K. Langbein currently holds 4,000 shares of DIALYSIS CORP OF AMERICA (DCAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas K. Langbein has been a net seller of DCAI stock. They have purchased $0 and sold $27.7K worth of shares.
Thomas K. Langbein's most recent insider trade was on Jun 2, 2010, when they sold 1,445,211 shares at $11.25 per share.
Thomas K. Langbein serves as Executive at DIALYSIS CORP OF AMERICA (DCAI). They have executed 18 insider transactions totaling $27.7K over their tenure at the company.
Thomas K. Langbein holds the position of Executive at DIALYSIS CORP OF AMERICA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Thomas K. Langbein has shown a selling trading pattern, with $0 in total purchases and $27.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas K. Langbein was on Jun 2, 2010, when they sold $16.3M worth of DCAI shares. This transaction involved 1,445,211 shares at $11.25 per share.
Thomas K. Langbein currently owns 4,000 shares of DIALYSIS CORP OF AMERICA (DCAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas K. Langbein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas K. Langbein has 18 Form 4 filings on record as an insider at DIALYSIS CORP OF AMERICA.
Set alerts for Thomas K. Langbein and 40,000+ other insiders.